These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 34677013)
41. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells. Johnson B; Opimba M; Bernier J Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784 [TBL] [Abstract][Full Text] [Related]
42. β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3. Fong JJ; Nguyen BL; Bridger R; Medrano EE; Wells L; Pan S; Sifers RN J Biol Chem; 2012 Apr; 287(15):12195-203. PubMed ID: 22371497 [TBL] [Abstract][Full Text] [Related]
43. Identification of O-linked N-acetylglucosamine (O-GlcNAc)-modified osteoblast proteins by electron transfer dissociation tandem mass spectrometry reveals proteins critical for bone formation. Nagel AK; Schilling M; Comte-Walters S; Berkaw MN; Ball LE Mol Cell Proteomics; 2013 Apr; 12(4):945-55. PubMed ID: 23443134 [TBL] [Abstract][Full Text] [Related]
44. Enrichment of O-GlcNAc-modified peptides using novel thiol-alkyne and thiol-disulfide exchange. Tsumoto H; Ogasawara D; Hashii N; Suzuki T; Akimoto Y; Endo T; Miura Y Bioorg Med Chem Lett; 2015 Jul; 25(13):2645-9. PubMed ID: 25980911 [TBL] [Abstract][Full Text] [Related]
45. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. Haltiwanger RS; Grove K; Philipsberg GA J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489 [TBL] [Abstract][Full Text] [Related]
46. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531 [TBL] [Abstract][Full Text] [Related]
47. Quantitative analysis of O-GlcNAcylation in combination with isobaric tag labeling and chemoenzymatic enrichment. Tsumoto H; Akimoto Y; Endo T; Miura Y Bioorg Med Chem Lett; 2017 Nov; 27(22):5022-5026. PubMed ID: 29029932 [TBL] [Abstract][Full Text] [Related]
48. Reversible hydrazide chemistry-based enrichment for O-GlcNAc-modified peptides and glycopeptides having non-reducing GlcNAc residues. Nishikaze T; Kawabata S; Iwamoto S; Tanaka K Analyst; 2013 Dec; 138(23):7224-32. PubMed ID: 24131013 [TBL] [Abstract][Full Text] [Related]
49. The Utilities of Chemical Reactions and Molecular Tools for O-GlcNAc Proteomic Studies. Kim EJ Chembiochem; 2015 Jul; 16(10):1397-409. PubMed ID: 26096757 [TBL] [Abstract][Full Text] [Related]
50. O-GlcNAcylation of the human epidermal growth factor receptor. Stateva SR; Villalobo A Org Biomol Chem; 2015 Aug; 13(30):8196-204. PubMed ID: 26108188 [TBL] [Abstract][Full Text] [Related]
53. Discovery of O-GlcNAc-6-phosphate modified proteins in large-scale phosphoproteomics data. Hahne H; Kuster B Mol Cell Proteomics; 2012 Oct; 11(10):1063-9. PubMed ID: 22826440 [TBL] [Abstract][Full Text] [Related]
54. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification. Vosseller K; Sakabe K; Wells L; Hart GW Curr Opin Chem Biol; 2002 Dec; 6(6):851-7. PubMed ID: 12470741 [TBL] [Abstract][Full Text] [Related]
55. Undetectable histone O-GlcNAcylation in mammalian cells. Gagnon J; Daou S; Zamorano N; Iannantuono NV; Hammond-Martel I; Mashtalir N; Bonneil E; Wurtele H; Thibault P; Affar el B Epigenetics; 2015; 10(8):677-91. PubMed ID: 26075789 [TBL] [Abstract][Full Text] [Related]
56. Transcriptional regulation of Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904 [TBL] [Abstract][Full Text] [Related]
57. Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration. Akan I; Olivier-Van Stichelen S; Bond MR; Hanover JA J Neurochem; 2018 Jan; 144(1):7-34. PubMed ID: 29049853 [TBL] [Abstract][Full Text] [Related]
58. Synthesis of a Highly Azide-Reactive and Thermosensitive Biofunctional Reagent for Efficient Enrichment and Large-Scale Identification of O-GlcNAc Proteins by Mass Spectrometry. Zhang W; Liu T; Dong H; Bai H; Tian F; Shi Z; Chen M; Wang J; Qin W; Qian X Anal Chem; 2017 Jun; 89(11):5810-5817. PubMed ID: 28510447 [TBL] [Abstract][Full Text] [Related]
59. Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy. Gurel Z; Sieg KM; Shallow KD; Sorenson CM; Sheibani N Mol Vis; 2013; 19():1047-59. PubMed ID: 23734074 [TBL] [Abstract][Full Text] [Related]
60. Next-generation unnatural monosaccharides reveal that ESRRB O-GlcNAcylation regulates pluripotency of mouse embryonic stem cells. Hao Y; Fan X; Shi Y; Zhang C; Sun DE; Qin K; Qin W; Zhou W; Chen X Nat Commun; 2019 Sep; 10(1):4065. PubMed ID: 31492838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]